10 studies found for:    LY2605541 | Phase 3
Show Display Options
Rank Status Study
1 Completed A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: LY2605541;   Drug: Insulin Lispro
2 Active, not recruiting A Study Comparing LY2605541 With Insulin Glargine as Basal Insulin Treatment
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: LY2605541;   Drug: Insulin Glargine
3 Completed A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: LY2605541;   Drug: Insulin glargine
4 Completed A Study in Patients With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Glargine;   Drug: LY2605541
5 Completed A Study to Compare a New Long-Acting Insulin (LY2605541) and Human Insulin NPH in Participants With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: LY2605541;   Drug: Human Insulin NPH
6 Completed A Study in Patients With Type I Diabetes Mellitus
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Glargine;   Drug: LY2605541;   Drug: Insulin Lispro
7 Completed A Study in Participants With Type 1 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Glargine;   Drug: LY2605541;   Drug: Insulin Lispro
8 Completed A Study in Participants With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: LY2605541;   Drug: Insulin Glargine;   Drug: Insulin Lispro
9 Not yet recruiting A Study of Insulin Peglispro (LY2605541) in Participants With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Insulin Peglispro;   Drug: Insulin Glargine
10 Recruiting A Study to Compare the Effect of Double Doses of Long-acting Insulin Therapies in Participants With Type 2 Diabetes
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Insulin Peglispro;   Drug: Insulin Glargine

Indicates status has not been verified in more than two years